ReviewDiscover oncology2023

Immune checkpoint blockade therapy for BRAF mutant metastatic colorectal cancer: the efficacy, new strategies, and potential biomarkers.

Jie Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.